Arca
Skip to content
Tools
Tools

ADRA1A: Alpha-1A adrenergic receptor

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Alpha-1 adrenergic receptors are G protein-coupled receptors for catecholamines that signal through the G(q) family of G proteins, including G(q) and G(11).

  • Drugs that act on it: 5
  • Approved: 3
  • In phases 1 to 3: 2
  • Sponsors: 4
  • Type: Protein

Who Is On It, and How Far Along

Every drug ChEMBL records acting on ADRA1A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved3

  • Phenylpropanolamine
  • Silodosin
  • Dapiprazole

Phase 30

    Phase 22

    • Dabuzalgron
    • Tedatioxetine

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      • H. Lundbeck A/S120%
      • NinaMED Pty Ltd120%

      Modalities

      Drugs on this target by ChEMBL molecule type.

      • Small molecule5100%

      The Landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 3 of 5 act as: Alpha-1a adrenergic receptor antagonist; the rest name their own mechanism.
      PhenylpropanolamineApprovedNinaMED Pty LtdSmall moleculeAgonistAlpha-1a adrenergic receptor agonist29Withdrawn
      SilodosinApprovedAbbVieSmall moleculeAntagonist—11—
      DapiprazoleApprovedFera PharmaceuticalsSmall moleculeAntagonist—0—
      DabuzalgronPhase 2—Small moleculePartial agonistAlpha-1a adrenergic receptor partial agonist0—
      TedatioxetinePhase 2H. Lundbeck A/SSmall moleculeAntagonist—0—

      Open Trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 16 in all, from ClinicalTrials.gov.
      Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial FibrillationPhenylpropanolamineNot applicableRecruitingChina National Center for Cardiovascular Diseases2026-10-16
      Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus HypersecretionPhenylpropanolaminePhase 4Not yet recruitingUniversity of North Carolina, Chapel Hill2026-10-14
      A Multicenter Randomized Cross-Over Study Evaluating the Efficacy and Safety of Silodosin in Adult Women With Voiding DysfunctionSilodosinPhase 2Not yet recruitingJaber Al Ahmad Al Sabah Hospital2026-09-16
      Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic ObstructionSilodosinPhase 4Active, not recruitingMansoura University2026-09-11
      Non-invasive Saphenous Nerve Stimulation Therapy for Overactive BladderPhenylpropanolaminePhase 3Not yet recruitingNinaMED Pty Ltd2026-08-24
      Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsSilodosinPhase 4Not yet recruitingMohsen Pourazizi2026-08-03
      Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia PatientsSilodosinPhase 4Not yet recruitingMohsen Pourazizi2026-08-03
      Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary DiseasePhenylpropanolamine—Active, not recruitingSeoul National University2026-07-17
      Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary RetentionSilodosinPhase 4RecruitingBeni-Suef University2026-06-16
      Silodosin for Urinary Symptoms in Female Patients With Multiple SclerosisSilodosinPhase 4RecruitingAtlantic Health System2026-05-29
      Safety and Efficacy of Conscious Sedation Versus General Anesthesia in Pulsed-Field Ablation for Paroxysmal Atrial FibrillationPhenylpropanolamineNot applicableActive, not recruitingBeijing Anzhen Hospital2026-04-21
      Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover TrialSilodosinPhase 4Not yet recruitingAin Shams University2026-03-12
      A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen SclerosusPhenylpropanolaminePhase 3RecruitingLEO Pharma2026-01-13
      Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical StudyPhenylpropanolaminePhase 4Not yet recruitingXinjiang Uygur Pharmaceutical Co., Ltd.2026-01-02
      An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain ServicePhenylpropanolaminePhase 3Not yet recruitingUniversity of California, San Francisco2025-12-22
      Sildosin as a Male Contraceptive Non HormonalSilodosinPhase 1Not yet recruitingBenha University2025-09-26

      Diseases Most Associated With It

      Open Targets association score, 0 to 1; all associations
      Benign prostatic hyperplasia
      0.61
      Hypertensive disorder
      0.61
      Nasal congestion
      0.61
      Cough
      0.60
      Asthma
      0.60
      Hemorrhoid
      0.59

      Genes and Related Targets

      Complexes and families that share a gene with this target
      Genes
      ADRA1A

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL229, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P35348, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.